The Saudi Arabia home diagnostic testing market was valued at USD 202.88 Million in 2024 and is expected to grow at a CAGR of 4.90%, reaching USD 327.34 Million by 2034 . The market growth is driven by the rising prevalence of chronic diseases, increasing demand for rapid and accurate home-based testing, and growing health awareness among Saudi Arabia’s aging population.
Other players in the market include Nova Biomedical, ACON Laboratories, Inc., OraSure Technologies, Inc., BTNX, Inc., ARKRAY Inc., and Siemens Healthcare GmbH.
This product will be delivered within 3-5 business days.
Key Trends and Insights
- By test type, infectious disease tests led the market in the historical period.
- Based on age group, the geriatric segment led the market with a revenue share of 60% in the historical period.
- In terms of sample type, urine tests accounted held the largest revenue share in the historical period.
Market Size and Forecast
- Market Size (2024): USD 202.88 Million
- Projected Market Size (2034): USD 327.34 Million
- CAGR (2025-2034): 4.90%
Saudi Arabia Home Diagnostic Testing Market Overview
Saudi Arabia’s market is growing rapidly due to rising healthcare awareness and the increasing prevalence of chronic conditions like diabetes, obesity, and cardiovascular diseases. Consumers are adopting home testing solutions for convenience, privacy, and timely monitoring. Government initiatives under Vision 2030 to enhance healthcare access and promote preventive care are driving adoption. Advanced technologies, including portable diagnostics and telemedicine integration, are improving test accuracy and accessibility. Market players focus on innovative, easy-to-use products, targeting both urban and rural populations, strengthening the overall healthcare ecosystem. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2025-2034.Saudi Arabia Home Diagnostic Testing Market Growth Drivers
Surge in Regulatory Approvals for At-Home Devices to Boost Market Growth
In September 2024, Biomerica received approval from the Saudi Food and Drug Authority (SFDA) for its Fortel® Prostate (PSA) Screening Test, a convenient at-home diagnostic kit for early prostate cancer detection. This launch addresses the growing demand for private, easy-to-use testing solutions among the aging male population. By enabling early detection without hospital visits, the product strengthens consumer confidence in home diagnostic testing. Biomerica’s approval highlights the market’s potential, encouraging both local and international companies to innovate and expand their home testing offerings in Saudi Arabia.Saudi Arabia Home Diagnostic Testing Market Trends
Major market trends include rising integration of digital platforms and emphasis on early screening for cancer.Increasing Integration of AI to Drive Home Testing Market Demand in the Forecast Period
In February 2025, ProvenMed launched Livv®, an AI-integrated home diagnostics platform providing smart test kits and digital lab services. This trend reflects the growing demand for technologically advanced, user-friendly home testing solutions in Saudi Arabia. By combining AI analysis with at-home kits, the platform enables early detection and continuous health monitoring. Increasing consumer interest in personalized, preventive healthcare and convenience is driving adoption, particularly among tech-savvy and health-conscious populations, supporting sustained growth in the home diagnostic testing market.Rise in Partnerships to Boost Saudi Arabia Home Diagnostic Testing Market Demand
In August 2025, SehaMed partnered with New Day Diagnostics to distribute ColoHealth™, the first FDA-approved blood test for early colorectal cancer detection in Saudi Arabia. This trend highlights the introduction of non-invasive, clinically validated home diagnostic tests in the region. By enabling early cancer detection outside traditional clinical settings, such initiatives drive consumer adoption, improve market credibility, and encourage healthcare providers to integrate home-based screening solutions, aligning with the rising focus on preventive healthcare and accessible, patient-friendly diagnostic technologies.Saudi Arabia Home Diagnostic Testing Market Share
Geriatric to Lead the Market Segmentation by Age Group
The geriatric segment dominated during the historical period, capturing around 60% of total revenue. This prominence is driven by the country’s aging population and the increasing prevalence of age-related chronic conditions, which require regular monitoring and early detection. Home diagnostic solutions offer elderly consumers convenience, privacy, and timely health insights, reducing the need for frequent hospital visits. As awareness of preventive healthcare grows, the geriatric segment is expected to continue leading the market, highlighting its critical role in shaping the landscape.Leading Players in the Saudi Arabia Home Diagnostic Testing Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:Becton, Dickinson and Company
Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company (BD) is a global leader in medical technology. In 2021, BD acquired Scanwell Health to enhance its digital at-home medical testing capabilities. In Saudi Arabia, BD offers a range of diagnostic solutions, including the BD Veritor Plus System, which provides rapid antigen testing for respiratory infections. The company has a significant presence in the region, with an office located in Riyadh.Abbott
Established in 1888 and headquartered in Abbott Park, Illinois, Abbott Laboratories is a global healthcare company. In Saudi Arabia, Abbott provides a wide array of diagnostic solutions, including the i-STAT System, a portable blood analyzer that delivers lab-accurate results in remote settings. The company operates offices in both Jeddah and Riyadh, serving hospitals, laboratories, and clinics across the Kingdom.Quidel Corporation
QuidelOrtho, formed through the merger of Quidel Corporation and Ortho Clinical Diagnostics, is a leading provider of in vitro diagnostics. The company offers a comprehensive portfolio of diagnostic solutions, including the Solana molecular testing platform, QuickVue rapid lateral-flow tests, and the Triage System. In Saudi Arabia, QuidelOrtho has a strong presence, with a dedicated team supporting clinical laboratories and healthcare providers.F. Hoffmann La Roche
Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche is a global pioneer in pharmaceuticals and diagnostics. The company offers a wide range of diagnostic tests and has a significant presence in the molecular diagnostics market. In Saudi Arabia, Roche Diagnostics operates through its subsidiary, Roche Diagnostics Saudi Arabia LLC, located in Riyadh. The company continues to innovate in diagnostic technologies, contributing to advancements in personalized healthcare.Other players in the market include Nova Biomedical, ACON Laboratories, Inc., OraSure Technologies, Inc., BTNX, Inc., ARKRAY Inc., and Siemens Healthcare GmbH.
Saudi Arabia Home Diagnostic Testing Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
- HIV Test Kits
- Diabetes and Glucose Test
- Cholesterol and Triglycerides Tests
- Pregnancy Tests
- Infectious Disease Tests
- Urinary Tract Infection Tests
- Ovulation Predictor Test Kits
- Others
Market Breakup by Product
- Strips
- Cassette
- Test Panel
- Midstream
- Dip Card
- Others
Market Breakup by Sample
- Urine
- Saliva
- Blood
- Others
Market Breakup by Age Group
- Pediatrics
- Adults
- Geriatrics
Market Breakup by Distribution Channel
- Retail Pharmacies/Drug Stores
- Hospital Pharmacies
- Online Pharmacies
Key Questions Answered in the Saudi Arabia Home Diagnostic Testing Market
- What was the Saudi Arabia home diagnostic testing market value in 2024?
- What is the Saudi Arabia home diagnostic testing market forecast outlook for 2025-2034?
- What is the market breakup based on test type?
- What is the market breakup based on product?
- What is the market breakup based on sample?
- What is the market segmentation based on age group?
- What is the market breakup based on the distribution channel?
- What are the major factors aiding the Saudi Arabia home diagnostic testing market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Saudi Arabia home diagnostic testing market trends?
- Which test type will lead the market segment?
- Which product will lead the market segment?
- Which application will lead the market segment?
- Which distribution channel will lead the market segment?
- Who are the key players involved in the Saudi Arabia home diagnostic testing market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Home Diagnostic Testing Market Overview
4 Saudi Arabia Home Diagnostic Testing Market Landscape
5 Saudi Arabia Home Diagnostic Testing Market Dynamics
6 Saudi Arabia Home Diagnostic Testing Market Segmentation (2018-2034)
8 Funding and Investment Analysis
9 Strategic Initiatives
10 Supplier Landscape
11 Saudi Arabia Home Diagnostic Testing Market - Distribution Model (Additional Insight)
Companies Mentioned
- Becton, Dickinson and Company
- Abbott
- Quidel Corporation
- F. Hoffmann La Roche
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2026 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 202.88 Million |
| Forecasted Market Value ( USD | $ 327.34 Million |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Saudi Arabia |
| No. of Companies Mentioned | 4 |
